 - Received any intravenous drug with potential anti-emetic effect within 24 hours prior to the start of study-designated chemotherapeutic agent or be scheduled to receive any drug of this type with the exception of administration of the palonosetrondexamethasone infusion solution at any time during the trial, including the following: 